Skip to main content

Atlas Venture — Portfolio, Page 3

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

115
Companies
$4.2B
Total invested
$68.0M
Avg. check
33
Industries
Biotechnology 17Therapeutics 10Medical 8Health Care 8Pharmaceutical 6Life Science 4+27 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 4972 of 115
Judo Bio
October 2024

Judo Bio is a biotechnology company that develops precision therapeutics targeting specific cell populations to address genetic diseases.

Biotechnology · Cambridge$75.0M Series A
Triveni Bio
October 2024

Triveni Bio is a a biotech company that develops functional antibodies targeting immunological and inflammatory disorders.

Biotechnology · Watertown$115.0M Series B
DC Connected
August 2024

DC Connected is a technology company focused on AI‑powered vehicle diagnostics and maintenance tools.

Analytics · Nersingen$2.3M Seed
PHINXT Robotics
August 2024

PHINXT Robotics enables warehouses of any size to deploy autonomous robots as needed, with no expertise required.

Robotics · London$2.5M Seed
Vigil Neuroscience
June 2024

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.

Biotechnology · Cambridge$40.0M Post Ipo Equity
Accent Therapeutics
January 2024

Accent Therapeutics is a biopharmaceutical company.

Biotechnology · Lexington$75.0M Series C
Comanche Biopharma
January 2024

Our purpose is to make every pregnancy around the world safer.

Biopharma · Concord$75.0M Series B
Remix Therapeutics
January 2024

Remix Therapeutics is a biotechnology company that is working on developing small molecule medicines.

Biotechnology · Cambridge$60.0M Series Unknown
Aiolos Bio
October 2023

Aiolos Bio is a biotech company developing innovative therapies for respiratory diseases and immune conditions.

Biopharma · San Francisco$245.0M Series A
Nvelop Therapeutics
September 2023

Nvelop Therapeutics is a biotechnology company that developes genetic medicines for patients with severe genetic diseases.

Biotechnology · Cambridge$100.0M Seed
Mariana Oncology
September 2023

Mariana Oncology is a biotechnology research industry.

Bioinformatics · Watertown$175.0M Series B
K36 Therapeutics
June 2023

K36 Therapeutics translate epigenetic modulation of oncogenic pathways into small molecule therapies.

Biotechnology · Cambridge$70.0M Series B
Ikena Oncology
May 2023

Ikena Oncology develops differentiated therapies to target cancer growth and resistance, focusing on Hippo and RAS signaling pathways.

Biotechnology · Boston$40.0M Post Ipo Equity
Matchpoint Therapeutics
October 2022

Matchpoint Therapeutics is a biotechnology company that integrates chemoproteomics, ML, and covalent chemistry to treat serious illnesses.

Biotechnology · Cambridge$70.0M Series A
Potato Play
February 2022

Potato Play is a Singapore-based publisher turning mobile games from Asia into worldwide hits.

Casual Games · Singapore$5.0M Seed
Arkuda Therapeutics
February 2022

Arkuda Therapeutics is a pharmaceutical company.

Biotechnology · Cambridge$64.0M Series B
Workmate
January 2022

Southeast Asia's Leading Marketplace for Frontline Workers

Employment · SingaporeSeries Unknown
Curie Therapeutics
December 2021

Curie Therapeutics is a fully integrated next-generation radiopharmaceutical firm that combines ligand research and radiochemistry experts.

Health Care · Boston$75.0M Series A
ShieldIOT
November 2021

ShieldIOT delivers innovative cybersecurity solutions that protect edge devices from security threats and operational risks.

Cyber Security · Herzliya$7.4M Series A
Rectify Pharmaceuticals
October 2021

Rectify Pharmaceuticals is a biotechnology company developing Positive Functional Modulators (PFMs), disease-modifying therapeutics.

Biotechnology · Cambridge$100.0M Series A
Ackcio
September 2021

Ackcio builds real-time, reliable, wireless, monitoring solutions for industrial applications.

Communications Infrastructure · Singapore$3.0M Series A
Versanis Bio
August 2021

Versanis Bio discovers and develops medicines that address medical conditions prevalent in older adults.

Biotechnology · Oakland$70.0M Series A
Vedere Bio ll
May 2021

Vedere Bio is developing gene therapy products to restore functional vision to patients who have suffered vision loss.

Biotechnology · Cambridge$77.0M Series A
Gemini Therapeutics
February 2021

Gemini Therapeutics focuses on genetically-defined dry age-related macular degeneration (AMD) and associated rare genetic diseases.

Biopharma · Cambridge$95.0M Post Ipo Equity

Where Atlas Venture invests

Biotechnology17
Therapeutics10
Medical8
Health Care8
Pharmaceutical6
Life Science4

About Atlas Venture's portfolio

How many companies has Atlas Venture invested in?

Atlas Venture has invested in 115 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Atlas Venture invest in?

Atlas Venture's top investment sectors include Biotechnology, Therapeutics, Medical, Health Care, Pharmaceutical. The firm invests across 33 different industry categories.

What is Atlas Venture's largest investment?

Among tracked funding rounds, Aiolos Bio received $245.0M in a Series A round. Atlas Venture's total known invested capital is $4.2B.

What is the average investment size for Atlas Venture?

Atlas Venture's average investment size is $68.0M across its portfolio of 115 companies.

What are Atlas Venture's most recent investments?

Recent Atlas Venture portfolio additions include Judo Bio, Triveni Bio, DC Connected, PHINXT Robotics, Vigil Neuroscience. These companies were founded in 2020 or later.

Reach the founders behind these 115 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →